| 56.17 Delayed Data As of Dec 12 |  +2.22 / +4.11%Today’s Change | 39.07 Today|||52-Week Range 59.81 | +11.67% Year-to-Date |
| Biotech Stock Roundup: Gilead to Get New CEO, Biogen In-Licenses Candidate Dec 12 / Zacks.com - Paid Partner Content | Biogen (BIIB) In-Licenses ALS Candidate BIIB067 From Ionis Dec 07 / Zacks.com - Paid Partner Content |
| Previous close | 53.95 |
| Today’s open | 54.52 |
| Day’s range | 53.73 - 56.51 |
| Volume | 988,739 |
| Average volume (3 months) | 1,179,697 |
| Market cap | $7.4B |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -369.56% |
| Earnings growth (next 5 years) | +28.00% |
| Revenue growth (last year) | +46.46% |
| P/E ratio | NM |
| Price/Sales | 12.49 |
| Price/Book | 20.31 |
| Today’s change | Today’s % change | |
|---|---|---|
| ALNYAlnylam Pharmaceutic... | +2.71 | +3.53% |
| SRPTSarepta Therapeutics... | +0.13 | +0.10% |
| AMRXAmneal Pharmaceutica... | -0.08 | -0.48% |
| RDYDr.Reddy's Laborator... | -1.29 | -3.47% |
| Next reporting date | February 25, 2019 |
| EPS forecast (this quarter) | $0.12 |
| Annual revenue (last year) | $507.7M |
| Annual profit (last year) | $9.7M |
| Net profit margin | 1.90% |
Sector Health Technology |
Industry Biotechnology |
Chairman, President & Chief Executive Officer Stanley T. Crooke |
Chief Operating Officer Brett P. Monia |
Corporate headquarters Carlsbad, California |
